Nicholas Smedley, Director of Mind Medicine Australia and Peter Hunt AM and Tania de Jong AM, Founders of Mind Medicine Australia are delighted to invite you to host a table at the:

Mind Medicine Australia Inaugural Annual Dinner with Special Guest Professor David Nutt, Head of Neuropsychopharmacology at Imperial College London (live in person)

Be sure to grab your tickets early!

This special event will feature a keynote by Professor Nutt titled ‘Psychedelic-Assisted Therapies: History, Neuroscience and Myths’, Q & A with audience plus fine food, wine and song.

Professor Nutt will explain:

The historic origins of psychedelic use, the rise of psychedelic therapy in psychiatry in the 1950s/60s and how this was destroyed by the War on Drugs
The new science of psychedelics in terms of brain activity that initiated trials in people with mental illness
The remarkable clinical outcomes from just one or two psychedelic treatments in conditions such as depression, trauma and addiction
How brain imaging studies have revealed the mechanisms by which psychedelics can produce such profound and enduring effects
What Australians can do to advance access to these breakthrough therapies.

You will be supporting Mind Medicine Australia’s mission to provide accessible and affordable psychedelic-assisted therapies to treat a range of mental illnesses in medically controlled environments. Mind Medicine Australia exists to help alleviate the suffering caused by our accelerating mental illness epidemic in Australia, through expanding the treatment options available to medical practitioners and their patients.

Don't miss out - book your tickets now!

Date: Wednesday 30th November 2022
Time: Arrive by 6:00pm for a 6:30pm start
Location: The Australian Club, 110 William St Melbourne
Ticket Price: $5000 Corporate VIP Table (This includes a $2,500 tax-deductible donation to Mind Medicine Australia which you will be able to further amplify at the event) / $500 Individual Ticket (including a $250 tax-deductible donation)

(All funds donated will go towards our mission to make these medicines available and accessible.)

Support psychedelic research and therapy development

By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.
Please click here to make a tax-deductible donation.

Disclaimer

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example facebook, instagram and zoom private and public chat forms during the webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.

Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.

OUR PARTNERS:

-----------------------------------------------------------------
About the Speakers

Professor David Nutt (UK)
BA, MB BChir, MRCP, MA, DM, MRC Psych, FRCPsych, FMedSci, FRCP, FSB
Ambassador of Mind Medicine Australia
Head of Neuropsychopharmacology at Imperial College London and the Chair of Drug Science

Renowned researcher, policy advisor and author, Professor David Nutt, is currently Head of Neuropsychopharmacology at Imperial College London and the Chair of Drug Science.

Under the leadership of Professor Nutt, the Psychedelic Research Group at Imperial College is one of the world’s foremost psychedelic research laboratories, publishing landmark research on psychedelic therapies and neuroimaging studies of the psychedelic state.

Professor Nutt has also held many leadership positions in both UK and European academic, scientific and clinical organisations, including presidencies of: the European Brain Council, the British Neuroscience Association, the British Association of Psychopharmacology, the European College of Neuropsychopharmacology.

He was previously Chair of the UK Advisory Council on the Misuse of Drugs.

Tania de Jong AM
LL.B (Hons), GradDipMus
Founder & Executive Director of Mind Medicine Australia

Tania de Jong AM is a trail-blazing Australian soprano, award-winning social entrepreneur, creative innovation catalyst, spiritual journey woman, storyteller and global speaker. Tania is one of Australia’s most successful female entrepreneurs and innovators developing 5 businesses and 4 charities over the past 3 decades. She is Founder and Executive Producer of future-shaping events series, Creative Innovation Global. She was appointed a Member of the Order of Australia in June 2008 and named one of the 100 Women of Influence and the 100 Australian Most Influential Entrepreneurs in 2018.

Peter Hunt AM
B.Com, LL.B
Founder & Chair of Mind Medicine Australia

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years. He co-founded and was Executive Chairman of one of Australia’s leading investment banking advisory firms, Caliburn Partnership (now called Greenhill Australia) and continued as Chairman of the Firm after its sale to Greenhill Inc in 2009. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world. He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He founded Women’s Community Shelter in 2011 and remains on the Board. He was previously Chairman of So They Can, Grameen Australia and Grameen Australia Philippines. Peter is a Director of Project Rozana and an Advisory Board member of the Monash Sustainable Development Institute. Peter also acts as a pro bono adviser to Creativity Australia.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Professor Jane Burns

BA (Hons), Ph.D, Director

Professor Jane Burns is a health strategist, advising the government, university and social enterprise sector. She is Chair of Open Arms, Chair of STREAT and Chair of the Centre for Mental Health at Swinburne University. She has over twenty years’ experience as a C-Suite Executive with high profile organisations, beyondblue: the national depression initiative and reachout.com and was the founder and CEO of the Young and Well Cooperative Research Centre raising over $100M in capital.

She is the Founder and Non-Executive Director of InnoWell and a Non-Executive Director with APPLI. She was a Harkness Fellow in Health Care Policy, a VicHealth Fellow in Health Promotion and an NHMRC Fellow in Suicide Prevention. In recognition for her achievements in entrepreneurship she won the category of Social Enterprise for 2015’s Australian Financial Review and Westpac Group 100 Women of Influence, and was a Victorian Finalist in the 2017 Telstra Business Women’s Awards.

Dr Eli Kotler

MBBS MPM FRANZCP Cert. Old Age Psych. AFRACMA

Psychiatrist and Medical Director at Malvern Private Hospital

Eli is a consultant psychiatrist, holds an academic position at Monash University through the Alfred Psychiatry Research Centre, and is the medical director of Malvern Private Hospital, the first addiction hospital in Australia. He is a member of the Australasian Professional Society on Alcohol and other Drugs (APSAD). Clinically, Eli is interested in the deep connections between trauma and addiction and works within a neuro-psychoanalytic framework. Eli has overseen the development of a clinical program for addictions focused on trauma, particularly developmental trauma. This has led to an interest in medication-assisted trauma therapy. Eli worked for many years researching neurodegenerative diseases and was the principle investigator on numerous trials for novel therapeutics. He is founding member of the Melbourne Neuropsychoanalytic Group and welcomes new members. Through involvement with Monash University, Eli oversees the addiction rotation for medical students.

Eli graduated from the first intake of the Certificate in Psychedelic-Assisted Therapies (CPAT) in June 2021. He has also been recently appointed as the Principal Investigator to lead Emyria’s upcoming MDMA trial.

Marjane Beaugeois

Phyto-Mycotherapist

Marjane is a trauma-informed addictions and mental health counsellor with over 7 year’s experience in spiritual healing practices and ancestral plant medicines.

Marjane grew up in France, completing a degree in Biology there, and then her Masters in Australia. Marjane undertook training as a trauma informed counsellor and has a strong understanding of the power of plants and medicinal fungi. She strongly believes in the power of psychedelic-assisted therapy for to help save lives.

Marjane has her own unique lived experiences of trauma, PTSD and anxiety and is now an active member of Mind Medicine Australia’s Melbourne Chapter, strongly advocating for urgent reform in Australia to enable these important plant medicines to be used in a clinical setting to help those who are suffering with a range of mental illnesses.